Pharmaceutical Investing ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement
Pharmaceutical Investing ACADIA Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for NUPLAZID (Pimavanserin)
